Investigating the mechanisms of perioperative ischemic stroke in the Carotid Occlusion Surgery Study

2013 ◽  
Vol 119 (4) ◽  
pp. 988-995 ◽  
Author(s):  
Matthew R. Reynolds ◽  
Robert L. Grubb ◽  
William R. Clarke ◽  
William J. Powers ◽  
Gregory J. Zipfel ◽  
...  

Object The Carotid Occlusion Surgery Study (COSS) was a large, prospective clinical trial that examined whether superficial temporal artery–middle cerebral artery (STA-MCA) bypass, in addition to best medical therapy, reduced the risk of ipsilateral ischemic stroke in patients with carotid artery occlusion and hemodynamic cerebral ischemia. Despite improved cerebral hemodynamics and excellent bypass graft patency rates, COSS failed to show a benefit for the surgical group with respect to ipsilateral stroke recurrence at 2 years after treatment. This was due to a lower than expected rate of recurrent ipsilateral stroke in the medically treated group and a high rate of perioperative ipsilateral strokes in the surgical group. Critics of the trial have cited surgeon inexperience and technical difficulties related to the performance of the bypass graft as a leading cause of failure of the trial. Methods The authors retrospectively identified all patients from the COSS with an ipsilateral, perioperative (< 30 days) ischemic stroke after STA-MCA cortical branch anastomosis. Study records, operative notes, stroke adjudication forms, and imaging studies were reviewed. Ischemic strokes were characterized as bypass graft related or non–bypass graft related based on clinical and radiographic findings. Results Fourteen of 93 surgically treated patients experienced an ipsilateral, perioperative ischemic stroke. Postoperatively, the mean oxygen extraction fraction (OEF) ratio between the symptomatic and asymptomatic cerebral hemisphere significantly improved in these patients (1.30 ± 0.18 preoperative vs 1.12 ± 0.11 postoperative; p = 0.02), but did not normalize. In this cohort, total MCA occlusion time during the anastomosis (54.3 ± 23.5 minutes) was no different from the MCA occlusion time in those surgical patients who did not have a perioperative stroke (45.4 ± 24.2 minutes, p = 0.2). Bypass graft patency rates in patients with a perioperative stroke were 92% at 30 days (11 of 12 patients with patency data) and 83% at last follow-up visit (10 of 12 patients with patency data). These patency rates were not significantly different from those achieved at 30 days (100%; 76 of 76 patients with patency data; p = 0.14) and at last follow-up (99%; 71 of 72 patients with patency data; p = 0.052) in patients without a perioperative stroke. Eighty-six percent (12 of 14 patients) of strokes were likely attributable to factors unrelated to the STA-MCA anastomosis. Only 21% of strokes (3 of 14 patients) were in the territory of the recipient vessel and likely related to technical performance of the anastomosis itself. One patient was thought to have dual stroke mechanisms. Conclusions Only a small minority of ipsilateral, perioperative ischemic strokes in the COSS could be attributed to technical problems of the bypass anastomosis. The majority of ischemic strokes could not be ascribed to this cause and were most likely due to patient hemodynamic fragility and the inability of patients to tolerate surgery.

2006 ◽  
Vol 55 (5) ◽  
pp. 451
Author(s):  
Seung Ho Joo ◽  
Byoung Wook Choi ◽  
Jae Seung Seo ◽  
Young Jin Kim ◽  
Tae Hoon Kim ◽  
...  

Vascular ◽  
2013 ◽  
Vol 21 (2) ◽  
pp. 75-78 ◽  
Author(s):  
Daniel Silverberg ◽  
Basheer Sheick-Yousif ◽  
Dmitry Yakubovitch ◽  
Moshe Halak ◽  
Jacob Schneiderman

The deep femoral artery (DFA) offers several advantages as an inflow vessel in lower-extremity bypasses. We report a single-center experience using the DFA as an inflow artery for lower-extremity revascularization. We reviewed all patients who underwent a lower-extremity bypass utilizing the DFA as the inflow vessel. Demographics, indications for surgery, indication for use of the DFA, type of conduits and target vessels were recorded. Follow-up data included resolution of symptoms, bypass graft patency, major amputations and survival. Over 2.5 years, 23 patients were treated with a DFA-inflow bypass. Eighteen (78%) suffered from wounds and five (22%) from rest pain. The proximal, middle and distal DFA was used in 8, 14 and 1 patients, respectively. Indications for using the DFA were limited vein conduit (16) and a hostile groin (5). All patients experienced initial resolution of their ischemic symptoms. The primary patency at two years was 93%. The survival rate was 83%. In conclusion, the DFA is an excellent and underutilized alternative inflow artery in patients requiring lower limb revascularization. It offers excellent patency rates and should be considered in patients with hostile groins or insufficient lengths of a vein conduit.


2020 ◽  
Vol 78 (6) ◽  
pp. 349-355
Author(s):  
Isaac Holanda Mendes MAIA ◽  
Thaissa Pinto de MELO ◽  
Fabrício Oliveira LIMA ◽  
João José de Freitas CARVALHO ◽  
Francisco José Arruda MONT’ALVERNE ◽  
...  

ABSTRACT Background: Malignant infarction of the middle cerebral artery (MCA) occurs in a subgroup of patients with ischemic stroke and early decompressive craniectomy (DC) is one of its treatments. Objective: To investigate the functional outcome of patients with malignant ischemic stroke treated with decompressive craniectomy at a neurological emergency center in Northeastern Brazil. Methods: Prospective cohort study, in which 25 patients were divided into two groups: those undergoing surgical treatment with DC and those who continued to receive standard conservative treatment (CT). Functionality was assessed using the modified Rankin Scale (mRS), at follow-up after six months. Results: A favorable outcome (mRS≤3) was observed in 37.5% of the DC patients and 29.4% of CT patients (p=0.42). Fewer patients who underwent surgical treatment died (25%), compared to those treated conservatively (52.8%); however, with no statistical significance. Nonetheless, the proportion of patients with moderate to severe disability (mRS 4‒5) was higher in the surgical group (37.5%) than in the non-surgical group (17.7%). Conclusion: In absolute values, superiority in the effectiveness of DC over CT was perceived, showing that the reduction in mortality was at the expense of increased disability.


2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Caiwu Zeng ◽  
Xiaomi Li ◽  
Yan Dai ◽  
Ye Zhou ◽  
Chenglong Li ◽  
...  

Abstract Objective This retrospective study sought to evaluate the efficacy of transit time flow measurement (TTFM) as a means of predicting bypass graft patency as assessed by coronary artery angiography upon 5-year follow-up. Methods Of 311 patients undergone isolated off-pump coronary artery bypass graft surgery from January 2014 through December 2014, 202 (65%) underwent both intraoperative TTFM and angiography at follow-up. 610 grafts, 202 left internal mammary artery grafts and 408 saphenous vein grafts were checked. Any grafts that exhibited Fitzgibbon type B or O lesions upon angiographic evaluation were considered to be failing. Receiver operating characteristic curves were used to identify the optimal TTFM values for predicting graft patency. Results A total of 610 grafts were included in this analysis, including 202 LIMA grafts and 408 SV grafts, of which 107, 129, 129, and 43 anastomosed to DIAG, OM, PDA, and PLA, respectively. LIMA, DIAG, OM, PDA, and PLA bypass grafts had overall patency rates of 95.0%, 74.8%, 73.6%, 71.5%, and 74.4%, respectively, upon 5-year follow up. No significant differences in TTFM values (MGF, PI, and DF) were observed when comparing outcomes associated with individual or sequential SV grafting. MGF was found to be predictive of graft failure regardless of the target vessel (P < 0.05). While PI was found to predict LIMA, OM, and PDA graft failure (P < 0.05), it was not associated with the failure of grafts associated with DIAG and PLA vessels. Similarly, DF was found to predict OM and PDA graft failure (P < 0.05), but was not significantly associated with the failure of grafts associated with LIMA, DIAG, or PLA vessels. Conclusion LIMA bypass grafts were associated with better 5-year graft patency relative to SV bypass grafts. Similar graft patency rates were observed for both individual and sequential bypass grafts. MGF was able to predict bypass graft failure in patients that underwent off-pump CABG surgery.


2020 ◽  
Author(s):  
caiwu zeng ◽  
Xiaomi Li ◽  
Yan Dai ◽  
Ye Zhou ◽  
Chenglong Li ◽  
...  

Abstract Objective: This retrospective study sought to evaluate the efficacy of transit time flow measurement (TTFM) as a means of predicting bypass graft patency as assessed by coronary artery angiography (CAG) upon 5-year follow-up. Method: Of 311 patients undergone isolated off-pump coronary artery bypass graft (CABG) surgery from January 2014 through December 2014, 202 (65%) underwent both intraoperative TTFM and angiography at follow-up. 610 grafts, 202 left internal mammary artery grafts and 408 saphenous vein grafts were checked. Any grafts that exhibited Fitzgibbon type B or O lesions upon angiographic evaluation were considered to be failing. Receiver operating characteristic (ROC) curves were used to identify the optimal TTFM values for predicting graft patency. Results: A total of 610 grafts were included in this analysis, including 202 LIMA grafts and 408 SV grafts, of which 107, 129, 129, and 43 anastomosed to DIAG, OM, PDA, and PLA, respectively. LIMA, DIAG, OM, PDA, and PLA bypass grafts had overall patency rates of 95.0%, 74.8%, 73.6%, 71.5%, and 74.4%, respectively, upon 5-year follow up. No significant differences in TTFM values (MGF, PI, and DF) were observed when comparing outcomes associated with individual or sequential SV grafting. MGF was found to be predictive of graft failure regardless of the target vessel (P<0.05). While PI was found to predict LIMA, OM, and PDA graft failure (P<0.05), it was not associated with the failure of grafts associated with DIAG and PLA vessels. Similarly, DF was found to predict OM and PDA graft failure (P<0.05), but was not significantly associated with the failure of grafts associated with LIMA, DIAG, or PLA vessels.Conclusion: LIMA bypass grafts were associated with better 5-year graft patency relative to SV bypass grafts. Similar graft patency rates were observed for both individual and sequential bypass grafts. TTFM was able to predict bypass graft failure in patients that underwent off-pump CABG surgery, with MGF cut-off values for LIMA, DIAG, OM, PDA, and PLA grafts being 14.5 mL/min, 14.5 mL/min, 14.5 mL/min, 13.5 mL/min, and 16.5 mL/min, respectively.


2014 ◽  
Vol 38 (1) ◽  
pp. 61-66 ◽  
Author(s):  
Zeyneb Yuceler ◽  
Mecit Kantarci ◽  
Ihsan Yuce ◽  
Yesim Kizrak ◽  
Ummugulsum Bayraktutan ◽  
...  

1975 ◽  
Author(s):  
M. T. McEnany ◽  
E. D. Mundth ◽  
R. M. Weintraub ◽  
R. W. DeSanctis ◽  
J. W. Harthorne ◽  
...  

Over 25,000 coronary artery bypass graft (CABG) procedures, involving more than 50,000 saphenous vein grafts, are performed yearly in the United States. The recognized one-year graft failure rate of 20-30% would imply thrombosis of at least 5,000 vein grafts per year. To improve graft patency rates, we have investigated the benefits of aspirin (ASA), warfarin (Coumadin®), or placebo in a randomized prospective study involving 216 patients undergoing CABG operations. A total of 412 vein grafts were performed. Clinical and angiographic follow-up at 1 to 2 years after operation is not yet completed, but preliminary results show 71% of grafts patent in ASA-treated patients, 64% in warfarin-treated patients, and 52% in the placebo group. 89% of warfarin-treated patients have at least one graft patent compared with 73% of placebo- and 75% of ASA-treated patients. The incidence of late myocardial infarctions has been lower in warfarin-treated (1.4%) and ASA-treated (4%) patients than in the placebo group (8%). Relief from angina is also markedly improved in treated groups, with 44% of ASA-treated and 56% of warfarin-treated patients angina free, compared to 27% of patients in the placebo group. There have been only 4 cardiac-related deaths, (3 in the placebo group and 1 in the ASA group). Eight patients were dropped from the study because of drugrelated problems. Four patients bled on warfarin therapy, one ASA patient bled, while two had ASA-allergic reactions and one developed gastritis. Follow-up is continuing.Preliminary results suggest that antithrombotic therapy is feasible in CABG patients and appears to promote graft patency, relieve angina pectoris and increase longevity.


Stroke ◽  
2020 ◽  
Vol 51 (Suppl_1) ◽  
Author(s):  
Maria C Zurru ◽  
Pedro Colla Machado ◽  
Natalia Balian ◽  
Ariel Luzzi ◽  
Laura Brescacin ◽  
...  

Background: Asymptomatic carotid plaques (ACP) generating less than 70% stenosis still have risk of complications.Our objective was to compare the incidence of silent lesions (SL) in patients with moderate stenosis (50-70%), severe stenosis (70-99%) or carotid occlusion, as well as the incidence of ipsilateral ischemic stroke or transient ischemic attack (TIA) during follow-up Material and method: cohort study of patients with carotid stenosis >50% by Doppler. LS were evaluated by MRI at admission and the end-points were ischemic stroke or TIA during follow-up. The study was approved by the Ethics Committee. Results: 646 patients were included from June 2010 to June 2018, 25% with bilateral stenosis >50%. Mean age 75 (ICR 53-79), 54% female. Sixty-three percent (n 507) had stenosis 70-99%, 31% (n 250) stenosis 50-70% and 6% (n 50) had carotid occlusion. SL were present in 15% (n 119) of the 807 plaques evaluated. Only limitrofe lesions were more prevalent in patients occlusion when comparing with severe and moderate stenosis:(20% vs 2% vs 1%, respectively; p 0.02 (table). Four patients had minor ipsilateral stroke (NIHSS < 5) during follow-up and 8 TIA; endarterectomy was performed in all of them. Clinical events did not occur in carotid occlusion, 3% (n 8) in moderate stenosis and 1% (n 4) in severe stenosis. Conclusion: SL incidence was not different in different stenosis degree, except for limitrofe infarcts in carotid occlusion (probably due to hemodynamic effect). Incidence of cerebrovascular complications was similar in patients with moderate and severe stenosis.


Sign in / Sign up

Export Citation Format

Share Document